Literature DB >> 8436184

Available lambda B cell repertoire in the mouse: evidence of positive selection by environmental factors.

B Nadel1, A M Drapier, P A Cazenave, P Sanchez.   

Abstract

We have recently shown that, from two BALB/c mice treated with rabbit anti-C lambda 2/C lambda 3 antibodies coupled to lipopolysaccharide, variable heavy chain (VH) family repertoires associated with lambda 2 or lambda 3 light chains can differ from one lambda subtype to another and from one individual mouse to another. Indeed, 4 out of 6 lambda 2 (VxJ2) hybridomas from one mouse preferentially expressed the VH10 family while 3 out of 8 lambda 2 (V2J2) and 5 out of 8 lambda 2 (VxJ2) hybridomas from a second mouse preferentially expressed the S107 and VGAM3.8 VH families, respectively. In this report, we describe the structural basis of such preferential pairings by sequence analysis of the 12 lambda 2 hybridomas. The sequence comparison of their VH regions show that each preferential association of a VH family to one V lambda region is restricted to the use of a single member or very closely related members inside a VH family and that a great variability of CDR3 of heavy chain is observed. We, therefore, suggest that environmental factors can modify the available lambda B cell repertoire through a positive selection of particular VH/V lambda pairings. Moreover, our data support that this selection does not require clonal expansion and punctual somatic mutation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8436184     DOI: 10.1002/eji.1830230236

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  2 in total

1.  Phospholipase Cgamma2 contributes to light-chain gene activation and receptor editing.

Authors:  Li Bai; Yuhong Chen; Yinghong He; Xuezhi Dai; Xueyan Lin; Renren Wen; Demin Wang
Journal:  Mol Cell Biol       Date:  2007-06-25       Impact factor: 4.272

2.  Light chain editing in kappa-deficient animals: a potential mechanism of B cell tolerance.

Authors:  E L Prak; M Trounstine; D Huszar; M Weigert
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.